ライフサイエンスコーパス: haemagglutination

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 mutations of psaE and psaF caused defective haemagglutination.

2 inia pseudotuberculosis pH6 antigen mediates haemagglutination and adhesion to cultured mammalian cel

3 and that mutations of these residues abolish haemagglutination and binding to type IV collagen.

4 n of these surface structures, which mediate haemagglutination and have a demonstrated role in virule

5 binding by B. burgdorferi is associated with haemagglutination and we have identified a 26 kDa protei

6 ard laboratory tests (the Treponema pallidum haemagglutination assay [TPHA] and the RPR test).

7 significant inhibition of P fimbria-mediated haemagglutination assay of uropathogenic Escherichia col

8 Haemagglutination assay proved it non-lectin.

9 antibodies that inhibited mannose-resistant haemagglutination by ETEC expressing CFA/I, CS4 and CS14

10 E. coli chi7122 conferred mannose-resistant haemagglutination (HA) and curli production to E. coli H

11 ed that the psaABC genes were sufficient for haemagglutination if they were expressed by a heterologo

12 s formed high levels of A/Cal-specific serum haemagglutination-inhibiting antibodies and were solidly

13 Samples with a haemagglutination inhibition (HI) titre >/=1ratio40 were

14 In the baseline serum samples from 2008, haemagglutination inhibition and microneutralisation ant

15 Antibody titres were measured by use of haemagglutination inhibition and microneutralisation ass

16 tal transfer of antibodies by measurement of haemagglutination inhibition and microneutralization tit

17 ersion and seroprotection, all determined by haemagglutination inhibition antibody assay.

18 this influenza nanoparticle vaccine elicited haemagglutination inhibition antibody titres more than t

19 y and efficacy of anti-influenza plasma with haemagglutination inhibition antibody titres of 1:80 or

20 and compared the proportion of samples with haemagglutination inhibition titre 1:32 or more (deemed

21 The proportion of samples with haemagglutination inhibition titre 1:32 or more ranged f

22 difference in the proportion of samples with haemagglutination inhibition titre equal to or above 1:3

23 Participants had to have an initial haemagglutination inhibition titre of at most 1/20, be a

24 ted participants had a four-fold increase in haemagglutination inhibition titres (group geometric mea

25 he placebo group had a four-fold increase in haemagglutination inhibition titres (group geometric mea

26 d high levels of influenza-specific IgG1 and haemagglutination inhibition titres to H1 virus.

27 Immunogenicity was assessed by haemagglutination inhibition titres, the percentage of p

28 Antibody responses were measured by haemagglutination inhibition, microneutralisation, and s

29 r, and one person of eleven seroconverted by haemagglutination inhibition, microneutralisation, H5N3

30 ccine gave the highest seroconversion rates: haemagglutination inhibition, six of ten; microneutralis

31 unogenicity endpoints were seroconversion by haemagglutination-inhibition (HAI), defined as a four-ti

32 subsequent immunisation were evaluated using haemagglutination-inhibition and microneutralisation ass

33 We measured antibody responses by haemagglutination-inhibition and microneutralisation.

34 Peak geometric mean titre (GMT) for haemagglutination-inhibition antibodies in the previousl

35 Importantly, higher cross-reactive haemagglutination-inhibition antibody titres against H5N

36 vaccinated with LAIV H5N2 had an increase in haemagglutination-inhibition titre of greater than four-

37 ants in the vaccine group had an increase in haemagglutination-inhibition titre of more than four-fol

38 pe 4 pilus responsible for mannose-sensitive haemagglutination is abolished.

39 uspension of A-cells or B-cells was used for haemagglutination on the reverse grouping side.

40 by the organism which are biofilm formation, haemagglutination properties and capsule production.

41 strains exhibited a strong mannose-sensitive haemagglutination reaction with guinea pig erythrocytes,

42 ctive combined serology (positive T pallidum haemagglutination test and rapid plasmin reagin titre of

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。